Quarterly report pursuant to Section 13 or 15(d)

Share-Based Payments (Tables)

v3.4.0.3
Share-Based Payments (Tables)
6 Months Ended
Mar. 31, 2016
Share-Based Payments [Abstract]  
Restricted stock activity
The transactions for restricted stock for the six months ended March 31, 2016 were as follows:

         
Weighted-
 
         
average
 
         
grant-date
 
   
Shares
   
fair value
 
Non-vested at September 30, 2015
   
570,567
   
$
33.66
 
Granted
   
224,125
     
51.91
 
Vested
   
(260,947
)
   
30.17
 
Expired or forfeited
   
(3,385
)
   
39.55
 
Non-vested at March 31, 2016
   
530,360
   
$
45.21
 
Stock option activity
The transactions for shares under options for the six months ended March 31, 2016 were as follows:

               
Weighted-
       
         
Weighted-
   
average
   
Aggregate
 
         
average
   
remaining
   
intrinsic
 
   
Shares
   
exercise price
   
contractual term
   
value
 
Outstanding, September 30, 2015
   
337,938
   
$
39.19
             
Exercised
   
(47,834
)
   
37.59
             
Expired or forfeited
   
(98,745
)
   
37.33
             
Outstanding, March 31, 2016
   
191,359
     
40.56
     
0.6
   
$
2,089
 
Exercisable, March 31, 2016
   
114,193
   
$
40.56
     
0.6
   
$
1,246
 
Non-vested options activity
The transactions for non-vested options for the six months ended March 31, 2016 were as follows:

         
Weighted-average
 
         
grant-date
 
Non-vested shares
 
Shares
   
fair value
 
Non-vested at September 30, 2015
   
166,406
   
$
12.43
 
Expired or forfeited
   
(89,240
)
   
12.56
 
Non-vested at March 31, 2016
   
77,166
   
$
12.29
 
Assumptions used in estimating fair value
The following table indicates the assumptions used in estimating fair value of restricted stock granted during the six-month periods ended March 31, 2016 and 2015.

   
Six Months Ended March 31,
 
   
2016
   
2015
 
Expected volatility
   
20.7
%
   
22.2
%
Dividend yield
   
1.0
%
   
1.0
%
Average risk-free interest rate
   
1.7
%
   
1.7
%
Average expected term (years)
   
2.1
     
1.8